• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-21 的上调与肾癌患者生存率降低相关。

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

机构信息

Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, United States of America.

出版信息

PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.

DOI:10.1371/journal.pone.0031060
PMID:22347428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3275568/
Abstract

BACKGROUND

MicroRNA-21 is up-regulated in a variety of cancers like, breast, colorectal, lung, head and neck etc. However, the regulation of miR-21 in renal cell carcinoma (RCC) has not yet been studied systematically.

METHODS AND RESULTS

We measured miR-21 levels in 54 pairs of kidney cancers and their normal matched tissues by real-time PCR. The expression level of miR-21 was correlated with 5 year survival and the pathological stage. Functional studies were done after inhibiting miR-21 in RCC cell lines. We studied in vitro and in vivo effects of the chemo preventive agent genistein on miR-21 expression. In 48 cases (90%), miR-21 was increased. All patients with low miR-21 expression survived 5 years, while with high miR-21 expression, only 50% survived. Higher expression of miR-21 is associated with an increase in the stage of renal cancer. Functional studies after inhibiting miRNA-21 in RCC cell lines show cell cycle arrest, induction of apoptosis and reduced invasive and migratory capabilities. Western blot analysis showed an increase in the expression of p21 and p38 MAP kinase genes and a reduction in cyclin E2. Genistein inhibited the expression of miR-21 in A-498 cells and in the tumors formed after injecting genistein treated A-498 cells in nude mice besides inhibiting tumor formation.

CONCLUSIONS

The current study shows a clear correlation between miR-21 expression and clinical characteristics of renal cancer. Thus we believe that miR-21 can be used as a tumor marker and its inhibition may prove to be useful in controlling cancers with up-regulated miR-21.

摘要

背景

miR-21 在多种癌症中上调,如乳腺癌、结直肠癌、肺癌、头颈部等。然而,miR-21 在肾细胞癌(RCC)中的调节尚未得到系统研究。

方法和结果

我们通过实时 PCR 测量了 54 对肾癌及其正常匹配组织中的 miR-21 水平。miR-21 的表达水平与 5 年生存率和病理分期相关。在 RCC 细胞系中抑制 miR-21 后进行功能研究。我们研究了化学预防剂金雀异黄素对 miR-21 表达的体外和体内影响。在 48 例(90%)中,miR-21 增加。所有低 miR-21 表达的患者均存活 5 年,而高 miR-21 表达的患者仅 50%存活。miR-21 的高表达与肾癌分期的增加有关。在 RCC 细胞系中抑制 miRNA-21 后的功能研究表明细胞周期停滞、诱导细胞凋亡以及降低侵袭和迁移能力。Western blot 分析显示 p21 和 p38 MAP 激酶基因的表达增加,细胞周期蛋白 E2 减少。金雀异黄素抑制 A-498 细胞中 miR-21 的表达,并抑制在裸鼠中注射金雀异黄素处理的 A-498 细胞形成的肿瘤形成。

结论

本研究表明 miR-21 的表达与肾癌的临床特征之间存在明确的相关性。因此,我们认为 miR-21 可以用作肿瘤标志物,其抑制可能对控制上调 miR-21 的癌症有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/9d26767411b2/pone.0031060.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/f9b892db99b3/pone.0031060.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/117a3beeb5b6/pone.0031060.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/9d26767411b2/pone.0031060.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/f9b892db99b3/pone.0031060.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/117a3beeb5b6/pone.0031060.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debe/3275568/9d26767411b2/pone.0031060.g005.jpg

相似文献

1
Up-regulation of microRNA-21 correlates with lower kidney cancer survival.miRNA-21 的上调与肾癌患者生存率降低相关。
PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.
2
Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.致癌 miR-23b-3p 抑制肾癌细胞中的 PTEN 基因表达。
PLoS One. 2012;7(11):e50203. doi: 10.1371/journal.pone.0050203. Epub 2012 Nov 26.
3
MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.MicroRNA-99a 诱导肾细胞癌细胞周期 G1 期阻滞并抑制肿瘤发生。
BMC Cancer. 2012 Nov 23;12:546. doi: 10.1186/1471-2407-12-546.
4
MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.微小 RNA-200b 在肾细胞癌中下调并通过靶向 LAMA4 抑制转移。
EBioMedicine. 2019 Jun;44:439-451. doi: 10.1016/j.ebiom.2019.05.041. Epub 2019 May 23.
5
Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.Mir-451与肾细胞癌患者的预后相关,并抑制肾细胞癌的细胞增殖。
Med Sci Monit. 2016 Jan 18;22:183-90. doi: 10.12659/msm.896792.
6
A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.一种新的环状 RNA,环状 NUP98,一种潜在的生物标志物,通过 miR-567/PRDX3 轴在肾细胞癌中发挥癌基因作用。
J Cell Mol Med. 2020 Sep;24(17):10177-10188. doi: 10.1111/jcmm.15629. Epub 2020 Jul 30.
7
miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.miR-1293 通过靶向氰酸酶 2 抑制肿瘤恶性转化:miR-1293/氰酸酶 2 轴在肾细胞癌中的治疗潜力。
Cancer Biother Radiopharm. 2020 Jun;35(5):377-386. doi: 10.1089/cbr.2019.2957. Epub 2020 Jan 22.
8
miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.miR-33a 通过下调 MDM4 的表达抑制肾癌细胞生长。
Mol Genet Genomic Med. 2019 Aug;7(8):e833. doi: 10.1002/mgg3.833. Epub 2019 Jun 28.
9
MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.微小 RNA-15a 在组织中的表达是透明细胞肾细胞癌患者生存的预后标志物。
Clin Exp Med. 2019 Nov;19(4):515-524. doi: 10.1007/s10238-019-00574-7. Epub 2019 Aug 22.
10
MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.肾细胞癌中肿瘤组织内的MiR-210表达及其沉默的体外效应
Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13.

引用本文的文献

1
MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications.泌尿系统癌症中的MicroRNA-21:从分子机制到临床意义
Front Cell Dev Biol. 2024 Jul 23;12:1437951. doi: 10.3389/fcell.2024.1437951. eCollection 2024.
2
Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics.植物生物活性化合物驱动的微小RNA(miRNA):一种靶向基因和癌症治疗的潜在来源及新策略。
Noncoding RNA Res. 2024 Jun 8;9(4):1140-1158. doi: 10.1016/j.ncrna.2024.06.003. eCollection 2024 Dec.
3
MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.

本文引用的文献

1
miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma.miR-21 通过靶向肾细胞癌中的多个基因调节细胞凋亡。
Urology. 2011 Aug;78(2):474.e13-9. doi: 10.1016/j.urology.2011.03.030.
2
Identification of a microRNA panel for clear-cell kidney cancer.用于透明细胞肾细胞癌的 microRNA 标志物的鉴定。
Urology. 2010 Apr;75(4):835-41. doi: 10.1016/j.urology.2009.10.033. Epub 2009 Dec 29.
3
miR-21 as a key regulator of oncogenic processes.微小RNA-21作为致癌过程的关键调节因子。
miR-183-5p 通过靶向 TET1 促进肾细胞癌转移。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231184997. doi: 10.1177/03946320231184997.
4
MicroRNA-155-5p Targets JADE-1, Promoting Proliferation, Migration, and Invasion in Clear Cell Renal Cell Carcinoma Cells.miR-155-5p 靶向 JADE-1,促进肾透明细胞癌细胞的增殖、迁移和侵袭。
Int J Mol Sci. 2023 Apr 25;24(9):7825. doi: 10.3390/ijms24097825.
5
Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava.基于微小RNA的风险分类器对伴有下腔静脉肿瘤血栓的肾细胞癌患者癌症特异性生存预测的批判性评估
Cancers (Basel). 2023 Mar 26;15(7):1981. doi: 10.3390/cancers15071981.
6
Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol.非编码RNA在膳食多酚抗癌作用中的贡献:绿原酸、姜黄素、表没食子儿茶素-3-没食子酸酯、染料木黄酮、槲皮素和白藜芦醇。
Antioxidants (Basel). 2022 Nov 28;11(12):2352. doi: 10.3390/antiox11122352.
7
Using Sequence Similarity Based on CKSNP Features and a Graph Neural Network Model to Identify miRNA-Disease Associations.基于序列相似性和图神经网络模型的 CKSNP 特征识别 miRNA-疾病关联。
Genes (Basel). 2022 Sep 28;13(10):1759. doi: 10.3390/genes13101759.
8
Effects of Genistein on Common Kidney Diseases.金雀异黄素对常见肾脏疾病的影响。
Nutrients. 2022 Sep 13;14(18):3768. doi: 10.3390/nu14183768.
9
Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health.利用 ncRNAs 作为癌症诊断和治疗的工具——迈向改善患者健康的个体化医疗之路。
Int J Mol Sci. 2022 Aug 19;23(16):9353. doi: 10.3390/ijms23169353.
10
Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs.膳食多酚通过 ROS 介导的途径及其对 microRNAs 的调节发挥抗癌作用。
Molecules. 2022 Jun 14;27(12):3816. doi: 10.3390/molecules27123816.
Biochem Soc Trans. 2009 Aug;37(Pt 4):918-25. doi: 10.1042/BST0370918.
4
MicroRNA profiling of human kidney cancer subtypes.人类肾癌亚型的微小RNA分析
Int J Oncol. 2009 Jul;35(1):109-14. doi: 10.3892/ijo_00000318.
5
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.肾细胞癌全基因组微小RNA表达谱分析:miR-141和miR-200c显著下调
J Pathol. 2008 Dec;216(4):418-27. doi: 10.1002/path.2437.
6
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.E2F1调控的微小RNA损害胃癌中转化生长因子β(TGFβ)依赖的细胞周期阻滞和细胞凋亡。
Cancer Cell. 2008 Mar;13(3):272-86. doi: 10.1016/j.ccr.2008.02.013.
7
Getting to the root of miRNA-mediated gene silencing.探寻miRNA介导的基因沉默的根源。
Cell. 2008 Jan 11;132(1):9-14. doi: 10.1016/j.cell.2007.12.024.
8
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.微小RNA-21(miR-21)在转录后下调肿瘤抑制因子程序性细胞死亡蛋白4(Pdcd4),并促进结直肠癌的侵袭、血管内侵入和转移。
Oncogene. 2008 Apr 3;27(15):2128-36. doi: 10.1038/sj.onc.1210856. Epub 2007 Oct 29.
9
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.微小RNA-21调节人类肝细胞癌中PTEN肿瘤抑制基因的表达。
Gastroenterology. 2007 Aug;133(2):647-58. doi: 10.1053/j.gastro.2007.05.022. Epub 2007 May 21.
10
Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.白细胞介素-6依赖的多发性骨髓瘤细胞存活涉及通过一个高度保守的增强子由Stat3介导的微小RNA-21的诱导。
Blood. 2007 Aug 15;110(4):1330-3. doi: 10.1182/blood-2007-03-081133. Epub 2007 May 11.